| Literature DB >> 34960255 |
Abstract
We observe that a residue R of the spike glycoprotein of SARS-CoV-2 that has mutated in one or more of the current variants of concern or interest, or under monitoring, rarely participates in a backbone hydrogen bond if R lies in the S1 subunit and usually participates in one if R lies in the S2 subunit. A partial explanation for this based upon free energy is explored as a potentially general principle in the mutagenesis of viral glycoproteins. This observation could help target future vaccine cargos for the evolving coronavirus as well as more generally. A related study of the Delta and Omicron variants suggests that Delta was an energetically necessary intermediary in the evolution from Wuhan-Hu-1 to Omicron.Entities:
Keywords: SARS-CoV-2 spike; backbone free energy; mutagenic pressure; vaccinology
Year: 2021 PMID: 34960255 PMCID: PMC8708592 DOI: 10.3390/vaccines9121509
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Summary statistics of variant mutagenic residues for the PDB-covered submolecule S of the SARS-CoV-2 spike glycoprotein (residues 27 to 1147) and its sub-molecules (residues 27 to 681) and (residues 682 to 1147). Averages are per residue in each molecule summed over the 15 structures in the third and fourth columns. A residue is missing if it is not modeled in the PDB file (interpreted as disorganized); is absent if it occurs in the PDB file but does not participate in either nearby backbone hydrogen bonds (along the backbone); and is unbonded if it is either missing or absent in at least 10 of the 15 PDB files in the database for that residue. In each case, the bar over the molecule denotes the subset of the mutated residues M of Wuhan-Hu-1 among the variants of concern or interest and those under monitoring, namely residues (5, 9, 12, 18–20, 26) 52, 67, 69–70, 75–76, 80, 95, 136, 138, 144–145, 152, 156–158, 190, 215, 243–244, 246–253, 346, 417, 449, 452, 478, 484, 490, 501, 570, 614, 641, 655, 677, 679, 681, 701, 716, 796, 859, 888, 899, 950, 982, 1027, 1071, 1092, 1101, and 1118 (1176), where the residues in parentheses are outside PDB-coverage and not reflected in this table. A residue contributes to the average free energy BFE only if it is bonded.
| Mol | #Res | avg #Missing | avg #Absent | avg #Unbonded | avg BFE |
|---|---|---|---|---|---|
| S | 1121 | 1.39 | 4.91 | 0.35 | 2.41 |
|
| 56 | 4.71 | 5.34 | 0.61 | 2.47 |
| S | 655 | 1.85 | 5.52 | 0.42 | 3.16 |
|
| 43 | 6.14 | 5.69 | 0.74 | 2.80 |
| S | 466 | 0.73 | 4.05 | 0.25 | 1.60 |
|
| 13 | 0.00 | 4.15 | 0.15 | 2.14 |
Figure 1Plot of BFE by the residue across the PDB-covered spike, namely residues 27–1147 of S. Illustrated in orange are the respective residue ranges for the N-terminal domain, the receptor-binding domain, the cleavage, the cleavage, and the first heptad repeat domain. The gray horizontal line indicates one “heat quantum” kcal/mole below zero. One can confirm by comparison with the structure itself that the intersections of BFE with this line corresponds to helices and, in fact, ones whose backbone geometry is especially near ideal helices according to considerations of free energy.
Figure 2Comparison of BFE across the spike from the single mutation D614G [27]. The BFE of Wuhan-Hu-1 is computed at each residue as the average of PDB structures 7KDG and 7KDH, which are stabilized in the prefusion conformation by mutations R682G, R683G, and R685G, plus the 2P mutation given by K986P and V987P; the BFE of the D614G mutation is computed as the average of structures 7KDK and 7KDL, analogously stabilized but also with the D614G mutation. In each case, missing or absent residues give null. Plotted is the difference of the former minus the latter. The Wuhan-Hu-1 BFE at residue 614, itself, is 2.26 kcal/mole compared to 2.12 kcal/mole for D614G, but despite this near equality at residue 614, the BFE across the entire spike is altered.
Percentage of unbonded residues for each indicated molecule. W, , and O are the Wuhan-Hu-1, Delta, and Omicron variants, respectively, and (*) denotes the collection of variants of concern or interest, or under monitoring from [2], with mutated residues given in Table 1. It is Tulio de Oliveira’s collection of mutated residues, namely 67, 69, 70, 142–145, 211, 212, 214, 339, 371, 373, 375, 417, 440, 446, 477, 478, 484, 493, 496, 498, 501, 505, 547, 614, 655, 679, 681, 764, 796, 856, 954, 969, and 981, that serve to define O for our purposes here. As in Table 1, we let , , and denote the collection of mutagenic residues M in each of the molecules S, namely , and , respectively, with M determined by (*) in the second column and by O in the third and fourth columns. The last column is simply the percentage of residues which are bonded in W and unbonded in in each molecule.
|
|
|
|
|
|
|---|---|---|---|---|
| S | 35 | 40 | 35 | 30 |
|
| 61 | 61 | 22 | 42 |
| S | 42 | 46 | 42 | 32 |
|
| 74 | 67 | 27 | 43 |
| S | 25 | 32 | 25 | 28 |
|
| 15 | 33 | 0 | 33 |